Projects

Mgr. Andrea Havranová

International

Current
  • European partnership fostering a European Research Area (ERA) for health research
    Program: Horizon Europe
    Duration: 1. 11. 2022 – 30. 10. 2029

National

Current
  • Effects of GLP-1 Analog on Multiple Sclerosis
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Role of modulation of enzymes endogenously producing H2S in tumor cells
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • Hepatic, lipid and cardiometabolic parameters changes in obese patients
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Effect of physical activity and nutrition on gut microbiota modification in healthy subjects and patients with a non - communicable diseases
    Program: SRDA
    Duration: 1. 8. 2018 – 30. 6. 2022
  • Physiological relevance of medical and pharmaceutical sciences.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2020
  • The role of myokines and adipokines in improvement of the cardiometabolic parameters following lifestyle changes in sedentary subjects
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
Employees